Diagnostics

Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.

Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery.  WILMINGTON, Del. ,…

5 months ago

Vendor Neutral Archive (VNA) Market to be Worth USD 1.3 billion by 2034, Growing a CAGR 12.6% – Exclusive Report by Transparency Market Research, Inc.

The improvement of patient care and compliance is expected to drive demand for a vendor-neutral archive market. A growing concern…

5 months ago

Lucid Diagnostics Launches New Corporate Website

NEW YORK, July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics…

5 months ago

Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC

SHANGHAI, July 11, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry…

5 months ago

Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and…

5 months ago

Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth

SAN DIEGO, July 11, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced over $277…

5 months ago

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic…

5 months ago

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in…

5 months ago

Hydreight Expands Its “At-Home Blood Testing” Solution with More Tests to All 50 States

In a joint-venture with a national laboratory, Hydreight and its medical network are expanding at-home lab tests spanning a range…

5 months ago

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential

Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potentialFS001…

5 months ago